These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody. Kim KS, Wass CA, Hong JK, Concepcion NF, Anthony BF. Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825 [Abstract] [Full Text] [Related]
24. The role of complement and antibody in opsonophagocytosis of type II group B streptococci. Baker CJ, Webb BJ, Kasper DL, Edwards MS. J Infect Dis; 1986 Jul; 154(1):47-54. PubMed ID: 3519791 [Abstract] [Full Text] [Related]
25. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. Smith CL, Baker CJ, Anderson DC, Edwards MS. J Infect Dis; 1990 Aug; 162(2):489-95. PubMed ID: 2197341 [Abstract] [Full Text] [Related]
29. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses. Feldman RG, Ferrante A. J Infect Dis; 1990 Oct; 162(4):883-7. PubMed ID: 2205651 [Abstract] [Full Text] [Related]
33. Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. Amaya RA, Baker CJ, Keitel WA, Edwards MS. J Am Geriatr Soc; 2004 Jan; 52(1):46-50. PubMed ID: 14687314 [Abstract] [Full Text] [Related]
34. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus. Choi MJ, Noh JY, Cheong HJ, Kim WJ, Lin SM, Zhi Y, Lim JH, Lim S, Seo HS, Song JY. Hum Vaccin Immunother; 2018 Jan 02; 14(1):67-73. PubMed ID: 28933634 [Abstract] [Full Text] [Related]
35. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL. J Exp Med; 1980 May 01; 151(5):1275-87. PubMed ID: 6989947 [Abstract] [Full Text] [Related]
36. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera. Fabbrini M, Rigat F, Rinaudo CD, Passalaqua I, Khacheh S, Creti R, Baldassarri L, Carboni F, Anderloni G, Rosini R, Maione D, Grandi G, Telford JL, Margarit I. Clin Infect Dis; 2016 Sep 15; 63(6):746-753. PubMed ID: 27402816 [Abstract] [Full Text] [Related]
37. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Vaccine; 2012 Jun 13; 30(28):4123-6. PubMed ID: 22537994 [Abstract] [Full Text] [Related]
38. Relative functional activity of purified human immunoglobulin G against a type III group B streptococcal strain. Kim KS, Kang JH, Concepcion NF, Anthony BF. Infect Immun; 1986 Jun 13; 52(3):908-10. PubMed ID: 3519467 [Abstract] [Full Text] [Related]
39. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus. De Cueninck BJ, Eisenstein TK, McIntosh TS, Shockman GD, Swenson RM. Infect Immun; 1983 Mar 13; 39(3):1155-60. PubMed ID: 6341229 [Abstract] [Full Text] [Related]
40. Fc receptor(s) induced by human cytomegalovirus bind differentially with human immunoglobulin G subclasses. Murayama T, Natsuume-Sakai S, Shimokawa K, Furukawa T. J Gen Virol; 1986 Jul 13; 67 ( Pt 7)():1475-8. PubMed ID: 3014057 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]